InterCure Ltd. (INCR)
NASDAQ: INCR · Real-Time Price · USD
0.9859
-0.0341 (-3.34%)
At close: Jan 12, 2026, 4:00 PM EST
0.9859
0.00 (0.00%)
After-hours: Jan 12, 2026, 7:04 PM EST
InterCure Employees
InterCure had 320 employees as of December 31, 2024. The number of employees increased by 50 or 18.52% compared to the previous year.
Employees
320
Change (1Y)
50
Growth (1Y)
18.52%
Revenue / Employee
$225,495
Profits / Employee
-$65,789
Market Cap
55.54M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 320 | 50 | 18.52% |
| Dec 31, 2023 | 270 | -100 | -27.03% |
| Dec 31, 2022 | 370 | 20 | 5.71% |
| Dec 31, 2021 | 350 | 275 | 366.67% |
| Dec 31, 2020 | 75 | 0 | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
INCR News
- 2 months ago - InterCure and Cannasoul Sign Strategic Investment and Collaboration Agreements to Advance Cannabis Science and Pharmaceutical Innovation - GlobeNewsWire
- 3 months ago - InterCure Reports First Half 2025 Results with NIS 130 Million in Revenue and Positive Operating Cash Flow - GlobeNewsWire
- 4 months ago - InterCure Announces Strategic Acquisition of ISHI, Unlocking Access to Premium U.S. Cannabis Technology and Brands - GlobeNewsWire
- 9 months ago - InterCure Announces FY2024 Results and Provides Q1 2025 Update: Revenue of NIS 239 Million and Adjusted EBITDA of NIS 24 Million, Strong Start to 2025 - PRNewsWire
- 11 months ago - InterCure Names Alexander Rabinovich as Chairman Replacing Ehud Barak - PRNewsWire
- 1 year ago - InterCure has Secured Funding of NIS 66M to support the recovery of Nir Oz Facility - PRNewsWire
- 1 year ago - Are Investors Missing The Forest? 35% Stock Drop Masks The International Potential Of This Weed Company - Benzinga
- 1 year ago - InterCure Announces First Half of 2024 Results: Revenue of NIS 126 million and Adjusted EBITDA of NIS 21 million - GlobeNewsWire